- 品名: 普諾賽SW626 (人卵巢癌細(xì)胞)
- 型號(hào): CL-0226
- 產(chǎn)品詳情
- 規(guī)格參數(shù)
產(chǎn)品信息
名稱 | SW626 (人卵巢癌細(xì)胞) (L15) (STR鑒定正確) (暫不出售) |
別稱 | SW-626; SW 626 |
背景描述 | The SW 626 cell line was initiated by A. Leibovitz in January 1974 at the Scott and White Clinic, Temple, Texas from a surgical specimen from a cystadenocarcinoma of the ovary in a 46 year old female Caucasian. Although originally thought to be of ovarian origin , a recent report has suggested that the SW 626 cell line might have been derived from an ovarian metastasis of a primary adenocarcinoma of the colon. |
種屬 | 人類 |
年齡(性別) | 女性,46歲 |
組織來(lái)源 | 子宮內(nèi)膜腺癌組織 |
生長(zhǎng)特性 | 貼壁細(xì)胞 |
細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
細(xì)胞類型 | 腫瘤細(xì)胞 |
腫瘤類型 | 卵巢癌細(xì)胞 |
生物安全等級(jí) | 1 |
生長(zhǎng)培養(yǎng)基 | Leibovitz's L-15+10% FBS+1% P/S |
推薦傳代比例 | 1:2-1:4 |
推薦換液頻率 | 2~3次/周 |
凍存條件 | 凍存液:55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO溫度:液氮 |
培養(yǎng)條件 | 氣相:空氣,100%溫度:37℃ |
致瘤性 | Yes, in nude mice produces well differentiated papillary adenocarcinomas consistent with ovarian primary. |
注意事項(xiàng) | 1、該細(xì)胞推薦使用Leibovitz's L-15培養(yǎng)基進(jìn)行培養(yǎng),Leibovitz's L-15不可以通入二氧化碳,會(huì)產(chǎn)生細(xì)胞毒性; 2、如您沒(méi)有無(wú)二氧化碳的培養(yǎng)箱,可使用DMEM替代Leibovitz's L-15,使用DMEM培養(yǎng)基時(shí)即可正常通入5%二氧化碳; 3、配套專用培養(yǎng)基默認(rèn)Leibovitz's L-15配置,如需DMEM配方,請(qǐng)聯(lián)系銷售下單備注更改。 |
保藏機(jī)構(gòu) | ATCC; HTB-78 ECACC; 91091203 |
STR鑒定
STR位點(diǎn)信息
Amelogenin X CSF1PO 11 D2S1338 25 D3S1358 15,17 D5S818 12 D7S820 12 D8S1179 11 D13S317 11 D16S539 11 D18S51 14 D19S433 14 D21S11 27,29 FGA 21,23 PentaD 9,13 PentaE 7,11 TH01 9.3 TPOX 8 vWA 17,18 D1S1656 15,17.3 D6S1043 11 D12S391 18,23
暫無(wú)內(nèi)容...